Search

Your search keyword '"Ashfield, Rebecca"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Ashfield, Rebecca" Remove constraint Author: "Ashfield, Rebecca" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
32 results on '"Ashfield, Rebecca"'

Search Results

1. Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination

6. Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells

8. Global vaccinology training: Report from an ADVAC workshop

10. Identification and Immune Assessment of T Cell Epitopes in Five Plasmodium falciparum Blood Stage Antigens to Facilitate Vaccine Candidate Selection and Optimization

11. Monoclonal TCR-redirected tumor cell killing

12. High affinity soluble ILT2 receptor: a potent inhibitor of CD8+ T cell activation

13. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools

14. Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels

15. Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies

18. A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis

19. Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions

20. Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions

21. Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors

22. Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system

23. Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors

24. Abstract 3525: IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma

25. Abstract 3528: IMCmage1: A novel bi-specific biologic re-directing T cells to kill MAGE-A3/A6 presenting cancers

26. Abstract 4744: Soluble, high affinity TCRs fused to anti-CD3 redirect T cells to kill cancer cells presenting MAGE-A3 and NY-ESO antigens

27. Abstract 1787: ImmTACs: Bi-functional reagents for redirected tumour cell killing

28. Abstract 5616: Soluble, high affinity TCRs fused to anti-CD3 redirect T cells to kill cancer cells presenting MAGE-A3 and NY-ESO antigens

29. The HLA A*0201–restricted hTERT540–548 peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor

31. High affinity soluble ILT2 receptor: a potent inhibitor of CD8+T cell activation

32. Arming oncolytic viruses with bispecific T cell engagers (BiTEs) for expression and secretion into the tumour microenvironment

Catalog

Books, media, physical & digital resources